About Us

We engineer modern tools to create a world where bioprocess is never the bottleneck

Culture’s commitment to innovation transforming the landscape of bioprocessing, enabling remote, scalable, and insight-rich offerings is both inspiring and an impactful testament to Culture’s approach to advancing biomanufacturing.
Darcy Birse

Where we’ve been, and where we’re going

ConsoleTM

With the goal of making bioprocess development as easy as possible, we designed ConsoleTM to be an intuitive way for scientists to design and analyze their experiments from the web.

2016
2018
2022
Coming Soon
2016

250mL bioreactor

Our 250 mL bioreactor was designed for fed-batch microbial and fermentation processes. We manufactured and scaled out these reactors to accommodate a growing customer base of therapeutics and synthetic biology customers.

Bioreactor simulation - Culture Bio
2016

ConsoleTM

With the goal of making bioprocess development as easy as possible, we designed ConsoleTM to be an intuitive way for scientists to design and analyze their experiments from the web.

5L bioreactor

After listening to our customers, we heard that their biggest need was material for process development. We launched our 5L reactors to enable large-batch material generation.

2022

Culture in your lab

We are developing a series of cloud-connected bioreactors, carts, and vessels that modularly plug into our customer’s existing lab infrastructure.

COMING SOON

Leadership

Darcy Birse
Chief Executive Officer
Sumeet Agrawal
VP of Strategy and Finance
Lisa Krallis
VP Commercial
Babu Sivaraman
VP of Product and R&D
Lauren Kellogg
VP of Corporate Development

Board of Directors

Beth Thompson-Webb
William Patrick
Risa Stack
Partner, The Production Board
Dan Phillips
Partner of Cultivian Sandbox and Sandbox Sustainability Ventures at Sandbox Industries
Andrew Lee
Principal at Northpond Ventures

Advisory Board

Joydeep Ganguly
Senior Vice President, Corporate Operations at Gilead Sciences, Inc
Bob Todd, PhD
Digital Process Design Pioneer and former Senior Vice President, Technology and Innovation at KBI Pharma
Phil Vanek, PhD
Chief Technology Officer at Gamma Biosciences
Eliana Clark PhD
Executive Vice President and Chief Technical Officer at Intellia Therapeutics, Inc.

Investors

Grow with
Culture

scientists with Bioreactors - Culture Bioscience